Stock Analysis / Study
Company: Crompton Greaves
Date: 10.09.2025
Key Valuation Metrics
-
Current Price: ₹319
-
Book Value: ₹48.26 → 10x above book value (Expensive)
-
P/E Ratio: 38.90 🌸 (Sector PE: 70.58 – Relatively Attractive)
-
ROCE: 19% 🌸 (Healthy)
-
ROE: 17.4% 🌸 (Good Return on Equity)
-
Face Value: ₹2
-
Beta: 0.71 🌸 (Low Volatility – Defensive Stock)
-
52W H/L: ₹469 / ₹301
Current Price: ₹319
Book Value: ₹48.26 → 10x above book value (Expensive)
P/E Ratio: 38.90 🌸 (Sector PE: 70.58 – Relatively Attractive)
ROCE: 19% 🌸 (Healthy)
ROE: 17.4% 🌸 (Good Return on Equity)
Face Value: ₹2
Beta: 0.71 🌸 (Low Volatility – Defensive Stock)
52W H/L: ₹469 / ₹301
📊 Forecast Price Range (H/M/L): ₹470 / ₹406 / ₹335
Quarterly Performance (June 2025 – YoY)
-
Sales: ↓ 7% 👎🏻 (Poor)
-
EBITDA: ↓ 18% 👎🏻 (Poor)
-
Net Profit: ↓ 19% 👎🏻 (Poor)
-
EPS: ↓ 19% 👎🏻 (Poor)
Sales: ↓ 7% 👎🏻 (Poor)
EBITDA: ↓ 18% 👎🏻 (Poor)
Net Profit: ↓ 19% 👎🏻 (Poor)
EPS: ↓ 19% 👎🏻 (Poor)
📉 Observation: Weak operational and bottom-line performance.
Dividend Policy
-
Dividend Frequency: Once a year (July)
-
Latest Dividend (July 2025): ₹3 per share 🌸
-
Record Date / Payout Date: [Data not provided]
Dividend Frequency: Once a year (July)
Latest Dividend (July 2025): ₹3 per share 🌸
Record Date / Payout Date: [Data not provided]
Seasonality Analysis (Historical Trends)
-
Jan: 3/9 Positive 👎🏻 (+2.89%)
-
Feb: 1/9 Positive 👎👎 (-4.31%) → Buy Opportunity
-
Mar: 5/9 Positive 👎🏻 (-1.46%)
-
Apr: 5/9 Positive 👎🏻 (+1.60%)
-
May: 7/9 Positive 🌸🌸 (+3.50%) → Sell & Book Profits
-
June: 8/10 Positive 🌸🌸 (+2.65%) → Sell & Book Profits
-
July: 7/10 Positive (+4.65%)
-
Aug: 8/9 Positive 🌸🌸 (+3.02%) → Sell Opportunity
-
Sep: 5/10 Positive 👎🏻 (-1.64%) → Buy Opportunity
-
Oct: 3/9 Positive 👎🏻 (-0.76%) → Buy Opportunity
-
Nov: 7/9 Positive 🌸🌸 (+0.96%) → Sell Opportunity
-
Dec: 4/9 Positive 👎🏻 (+2.25%)
Jan: 3/9 Positive 👎🏻 (+2.89%)
Feb: 1/9 Positive 👎👎 (-4.31%) → Buy Opportunity
Mar: 5/9 Positive 👎🏻 (-1.46%)
Apr: 5/9 Positive 👎🏻 (+1.60%)
May: 7/9 Positive 🌸🌸 (+3.50%) → Sell & Book Profits
June: 8/10 Positive 🌸🌸 (+2.65%) → Sell & Book Profits
July: 7/10 Positive (+4.65%)
Aug: 8/9 Positive 🌸🌸 (+3.02%) → Sell Opportunity
Sep: 5/10 Positive 👎🏻 (-1.64%) → Buy Opportunity
Oct: 3/9 Positive 👎🏻 (-0.76%) → Buy Opportunity
Nov: 7/9 Positive 🌸🌸 (+0.96%) → Sell Opportunity
Dec: 4/9 Positive 👎🏻 (+2.25%)
Financial Strength & Shareholding
-
Piotroski Score: 7 🌸🌸 (Very Good – Strong Financial Position)
-
FII Holding: 29.20% (Previous: 30.34%) ⬇️
-
DII Holding: 58.93% (Previous: 57.04%) ⬆️
-
Promoter Holding: Unchanged
-
Total Institutional Investors: 88.13% (Previous: 87.38%) ⬆️
Piotroski Score: 7 🌸🌸 (Very Good – Strong Financial Position)
FII Holding: 29.20% (Previous: 30.34%) ⬇️
DII Holding: 58.93% (Previous: 57.04%) ⬆️
Promoter Holding: Unchanged
Total Institutional Investors: 88.13% (Previous: 87.38%) ⬆️
Investment Strategy (Seasonality-Based)
For Maximum Profit Potential:
-
Buy in Feb → Sell in May–June–July–Aug
-
Buy in Sep–Oct → Sell in Nov–Dec
Verdict
-
Valuation: Expensive (10x Book Value), but supported by strong ROCE & ROE.
-
Performance: Current quarter results weak 👎🏻.
-
Positives: Strong institutional holding, low beta, good Piotroski score.
-
Negatives: Sales and profit decline, high valuation.
Valuation: Expensive (10x Book Value), but supported by strong ROCE & ROE.
Performance: Current quarter results weak 👎🏻.
Positives: Strong institutional holding, low beta, good Piotroski score.
Negatives: Sales and profit decline, high valuation.
Disclaimer
This document is purely for educational and analytical purposes only. It represents personal study, data interpretation, and thought-provoking observations. It does not constitute investment advice or a recommendation. Investors must make independent decisions after consulting certified financial advisors, taking into account their own objectives and risk appetite.
Stock Analyze /Self Study on 10.09.2025
Crompton Greaves
Current Price: 317 (10 time Above Book Value: 48.26)
P-Poor👎🏻
G- Good 🌸
D-Dividend
B-Buy
S-Sell
HD-Hold 😅
HH-High 👍🏻
L-Low 👎🏻
M- Mean
--------------------------------------
Result :June Result ⬇️ % YOY
Sale : (-7%) Poor👎🏻
EBIDT: (-18%) Poor👎🏻
Net Profit:(-19%) Poor👎🏻
EPS;: (-19%) Poor👎🏻
-------------------------------------
Paying dividend 1 time in year (3/- in July)
Dividend Announce :🌸 3/- per Share (already paid in July )
Record date :
Payout date :
--------------------------------------
Current Price: 319
52W H/L: 469/301
PE: 38.90 (Good🌸)
PE Sector: 70.58
ROCE:19% (Good🌸)
ROE: 17.4 (Good🌸)
Book Value :48.26 (Low)
Face Value:2
Beta: 0.71 (Good🌸)
Forcast:H/M/L
470/406/335
-------------------------------------
Seasonality
Positive result in
Jan: 3/9 (Poor,👎) (+2.89%)
Feb:1/9( V.poor👎👎) (-4.31) Buy
Mar:5/9 (Poor 👎) (-1.46%)
Apr:5/9 (Poor 👎)(+1.60)
May: 7/9 (V.good🌸🌸)(+3.50%)
(Sell and book Profit)
June:8/10( V.good🌸🌸)(+2.65%)
(Sell and book Profit)
July: 7/10 (+4.65%)
Aug :8/9 (V.good🌸🌸) (+3.02%) sell
Sep:5/10(Poor👎) (-1.64%) Buy
Oct: 3/9 (Poor👎) (-0.76%) Buy
Nov:7/9 (V.Good🌸🌸)(+0.96%) Sell
Dec:4/9 (Poor👎)(+2.25%)
–-------------------------------------
Piotroski Score : 7 🌸🌸 (V.Good) Strong Finance
FII: 29.20% (30.34)
DII: 58.93% (57.04%)
Promoter:unchange
Institution Invester : 88.13% (87.38%)
⬆️⬇️ 🌸👍🏻👎🏻😅current% (old%)
------------------------------------
Shareholding max upto
In current case -Nov
For Max Profit
1. Buy in Feb,---Sell in May-June-July-August,
2. Buy in Sep - Oct Sell in Nov-Dec
Disclaimer:
The purpose of this article is only to share interesting charts, data points and thought-provoking opinions. It is NOT a recommendation. If you wish to consider an investment, you are strongly advised to consult your advisor. This article is strictly for educative purposes only.
No comments:
Post a Comment